Home/Filings/4/0000914190-20-000423
4//SEC Filing

Spandow Oliver J. 4

Accession 0000914190-20-000423

CIK 0001196298other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:28 PM ET

Size

8.4 KB

Accession

0000914190-20-000423

Insider Transaction Report

Form 4
Period: 2020-11-18
Transactions
  • Purchase

    Common Stock

    2020-11-18$5.83/sh+1,500$8,74915,734 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
    5,568
  • Stock Option (Right to Buy)

    Exercise: $5.58Exp: 2028-08-10Common Stock (9,466 underlying)
    9,466
  • Stock Option (Right to Buy)

    Exercise: $5.85Exp: 2028-12-19Common Stock (5,161 underlying)
    5,161
Footnotes (3)
  • [F1]The option vests as to 3,156 shares on 8/10/19 and as to 3,155 shares on each of 8/10/20 and 8/10/21.
  • [F2]The option vests as to 1,721 shares on 12/19/18 and as to 1,720 shares on each of 12/19/19 and 12/19/20.
  • [F3]The option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001749836

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:28 PM ET
Size
8.4 KB